Pesquisa | BVS Educação Profissional em Saúde

1.

Atezolizumab for Advanced Alveolar Soft Part Sarcoma.

Chen, Alice P; Sharon, Elad; O'Sullivan-Coyne, Geraldine; Moore, Nancy; Foster, Jared C; Hu, James S; Van Tine, Brian A; Conley, Anthony P; Read, William L; Riedel, Richard F; Burgess, Melissa A; Glod, John; Davis, Elizabeth J; Merriam, Priscilla; Naqash, Abdul R; Fino, Kristin K; Miller, Brandon L; Wilsker, Deborah F; Begum, Asma; Ferry-Galow, Katherine V; Deshpande, Hari A; Schwartz, Gary K; Ladle, Brian H; Okuno, Scott H; Beck, Jill C; Chen, James L; Takebe, Naoko; Fogli, Laura K; Rosenberger, Christina L; Parchment, Ralph E; Doroshow, James H.

N Engl J Med ; 389(10): 911-921, 2023 Sep 07.

Artigo em Inglês | MEDLINE | ID: mdl-37672694

2.

A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.

Somaiah, Neeta; Van Tine, Brian Andrew; Wahlquist, Amy E; Milhem, Mohammed M; Hill, Elizabeth G; Garrett-Mayer, Elizabeth; Armeson, Kent E; Schuetze, Scott M; Meyer, Christian F; Reuben, Daniel Y; Elias, Anthony D; Read, William L; Chawla, Sant P; Kraft, Andrew S.

Cancer ; 127(6): 894-904, 2021 03 15.

Artigo em Inglês | MEDLINE | ID: mdl-33231866

3.

Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma.

McCracken, D Jay; Celano, Emma C; Voloschin, Alfredo D; Read, William L; Olson, Jeffrey J.

J Neurooncol ; 130(1): 193-201, 2016 10.

Artigo em Inglês | MEDLINE | ID: mdl-27502784

4.

Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic Neurotoxicity.

Menon, Ambika; Enunwa, Chidiebele A; Read, William L; James, Kyle P.

Case Rep Oncol ; 17(1): 202-207, 2024.

Artigo em Inglês | MEDLINE | ID: mdl-38322300

5.

A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery.

Rosenbaum, Evan; Chugh, Rashmi; Ryan, Christopher W; Agulnik, Mark; Milhem, Mohammed M; George, Suzanne; Jones, Robin L; Chmielowski, Bartosz; Van Tine, Brian A; Tawbi, Hussein; Elias, Anthony D; Read, William L; Budd, G Thomas; Qin, Li-Xuan; Rodler, Eve T; Hirman, Joe; Weiden, Paul; Bennett, Cathryn M; Livingston, Philip O; Ragupathi, Govind; Hansen, David; D'Angelo, Sandra P; Tap, William D; Schwartz, Gary K; Maki, Robert G; Carvajal, Richard D.

Eur J Cancer ; 176: 155-163, 2022 11.

Artigo em Inglês | MEDLINE | ID: mdl-36215947

6.

A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma.

McElroy, Michele K; Read, William L; Harmon, Gregory S; Weidner, Noel.

Ann Diagn Pathol ; 15(5): 370-5, 2011 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-20952278

7.

A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors.

Traynor, Anne M; Gordon, Michael S; Alberti, Dona; Mendelson, David S; Munsey, Mark S; Wilding, George; Gammans, Richard E; Read, William L.

Invest New Drugs ; 28(4): 509-15, 2010 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-19434370

8.

Pulmonary langerhans cell histiocytosis diagnosed in a cervical lymph node: a case report.

Scuderi, Richard T; Makani, Samir S; Channick, Colleen L; Renner, John W; Alexander, Thomas H; Brumund, Kevin T; Read, William L; Weidner, Noel.

Acta Cytol ; 54(4): 618-22, 2010.

Artigo em Inglês | MEDLINE | ID: mdl-20715667

9.

Dose-response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin.

Lorza, Andres M Arias; Ravi, Harshan; Philip, Rohit C; Galons, Jean-Philippe; Trouard, Theodore P; Parra, Nestor A; Von Hoff, Daniel D; Read, William L; Tibes, Raoul; Korn, Ronald L; Raghunand, Natarajan.

Sci Rep ; 10(1): 14449, 2020 09 02.

Artigo em Inglês | MEDLINE | ID: mdl-32879326

10.

Recurrent Epithelioid Hemangioma of the Bony Pelvis Responding to Propranolol.

Broida, Sam; Reimer, Nickolas; Read, William L.

Case Rep Oncol ; 12(3): 704-708, 2019.

Artigo em Inglês | MEDLINE | ID: mdl-31607887

11.

The use of a predictive statistical model to make a virtual control arm for a clinical trial.

Switchenko, Jeffrey M; Heeke, Arielle L; Pan, Tony C; Read, William L.

PLoS One ; 14(9): e0221336, 2019.

Artigo em Inglês | MEDLINE | ID: mdl-31483824

12.

Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.

Huang, Raymond Y; Unadkat, Prashin; Bi, Wenya Linda; George, Elizabeth; Preusser, Matthias; McCracken, Jay D; Keen, Joseph R; Read, William L; Olson, Jeffrey J; Seystahl, Katharina; Le Rhun, Emilie; Roelcke, Ulrich; Koeppen, Susanne; Furtner, Julia; Weller, Michael; Raizer, Jeffrey J; Schiff, David; Wen, Patrick Y.

Neuro Oncol ; 21(2): 234-241, 2019 02 14.

Artigo em Inglês | MEDLINE | ID: mdl-30085283

13.

A phase I study of bexarotene and rosiglitazone in patients with refractory cancers.

Read, William L; Baggstrom, Maria Q; Fracasso, Paula M; Govindan, Ramaswamy.

Chemotherapy ; 54(3): 236-41, 2008.

Artigo em Inglês | MEDLINE | ID: mdl-18560232

14.

Recurrent Meningioma of the Cervical Spine, Successfully Treated with Liposomal Doxorubicin.

Read, William L; Williams, Felicia.

Case Rep Oncol ; 10(2): 656-659, 2017.

Artigo em Inglês | MEDLINE | ID: mdl-28868027

15.

Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases.

Read, William L; Trivedi, Sumita; Williams, Felicia.

Gynecol Oncol Rep ; 22: 75-77, 2017 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-29062884

16.

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Holdhoff, Matthias; Ye, Xiaobu; Supko, Jeffrey G; Nabors, Louis B; Desai, Arati S; Walbert, Tobias; Lesser, Glenn J; Read, William L; Lieberman, Frank S; Lodge, Martin A; Leal, Jeffrey; Fisher, Joy D; Desideri, Serena; Grossman, Stuart A; Wahl, Richard L; Schiff, David.

Neuro Oncol ; 19(6): 845-852, 2017 06 01.

Artigo em Inglês | MEDLINE | ID: mdl-28371832

17.

Metastatic Angiosarcoma with Kasabach-Merritt Syndrome Responsive to Gemcitabine and Vinorelbine after Failure of Liposomal Doxorubicin and Paclitaxel: A Case Report.

Read, William L; Williams, Felicia.

Case Rep Oncol ; 9(1): 177-81, 2016.

Artigo em Inglês | MEDLINE | ID: mdl-27065850

18.

Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases.

Read, William L; Williams, Felicia.

Case Rep Oncol ; 9(3): 639-643, 2016.

Artigo em Inglês | MEDLINE | ID: mdl-27920695

19.

Differential prognostic impact of comorbidity.

Read, William L; Tierney, Ryan M; Page, Nathan C; Costas, Irene; Govindan, Ramaswamy; Spitznagel, Edward L J; Piccirillo, Jay F.

J Clin Oncol ; 22(15): 3099-103, 2004 Aug 01.

Artigo em Inglês | MEDLINE | ID: mdl-15284260

20.

Community-acquired bacterial meningitis.

Read, William L.

N Engl J Med ; 354(13): 1429-32; author reply 1429-32, 2006 Mar 30.

Artigo em Inglês | MEDLINE | ID: mdl-16575956

BVS Educação Profissional em Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Atezolizumab for Advanced Alveolar Soft Part Sarcoma.

A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.

Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma.

Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic Neurotoxicity.

A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery.

A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma.

A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors.

Pulmonary langerhans cell histiocytosis diagnosed in a cervical lymph node: a case report.

Dose-response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin.

Recurrent Epithelioid Hemangioma of the Bony Pelvis Responding to Propranolol.

The use of a predictive statistical model to make a virtual control arm for a clinical trial.

Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.

A phase I study of bexarotene and rosiglitazone in patients with refractory cancers.

Recurrent Meningioma of the Cervical Spine, Successfully Treated with Liposomal Doxorubicin.

Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases.

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Metastatic Angiosarcoma with Kasabach-Merritt Syndrome Responsive to Gemcitabine and Vinorelbine after Failure of Liposomal Doxorubicin and Paclitaxel: A Case Report.

Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases.

Differential prognostic impact of comorbidity.

Community-acquired bacterial meningitis.